Hepatitis Monthly

Published by: Kowsar

Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study

Nasser Mostafavi 1 , Roya Kelishadi 1 , Elham Kazemi 2 , Behrooz Ataei 3 , Majid Yaran 4 , Mohammad Esmaeil Motlagh 5 , Mostafa Qorbani 6 , 7 , Ramin Heshmat 7 , Mohamad Hasan Tajadini 8 and Shervin Ghaffari Hoseini 2 , *
Authors Information
1 Pediatrics Department, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
4 Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
5 Pediatrics Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
6 Department of Community Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, IR Iran
7 Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, IR Iran
8 Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Hepatitis Monthly: September 01, 2016, 16 (9); e36437
  • Published Online: August 17, 2016
  • Article Type: Research Article
  • Received: January 18, 2016
  • Revised: May 4, 2016
  • Accepted: August 10, 2016
  • DOI: 10.5812/hepatmon.36437

To Cite: Mostafavi N, Kelishadi R, Kazemi E, Ataei B, Yaran M, et al. Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study, Hepat Mon. 2016 ; 16(9):e36437. doi: 10.5812/hepatmon.36437.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Saberifiroozi M. Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health. Hepat Mon. 2011; 11(4): 235-7[PubMed]
  • 2. WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec. 2012; 87(28/29): 261-76[PubMed]
  • 3. Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, et al. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect. 2016; 144(2): 291-6[DOI][PubMed]
  • 4. Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, et al. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014; 19-63[PubMed]
  • 5. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010; 13(2): 99-104[PubMed]
  • 6. Karimi A, Imani-Rastabi R, Moezzi M, Moradi MT. Hepatitis a seroprevalence and associated risk factors: A community-based cross-sectional study in shahrekord, iran. Arch Clin Infect Dis. 2016; 11(1)
  • 7. Kazemi SA, Mahram M, Koosha A, Amirmoghaddami HR. Seroprevalence of hepatitis a in 7-10 year-old children. Iran J Pediatr. 2007; 17(1): 47-51
  • 8. Asaei S, Ziyaeyan M, Moeini M, Jamalidoust M, Behzadi MA. Seroprevalence of Hepatitis A and E Virus Infections Among Healthy Population in Shiraz, Southern Iran. Jundishapur J Microbiol. 2015; 8(7): 19311[DOI][PubMed]
  • 9. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011; 11(4): 285-8[PubMed]
  • 10. Rafeey M, Shoaran M. Prevalence and risk factors of hepatitis a in children in tabriz, iran. J Anal Res Clin Med. 2014; 2(4): 183-6
  • 11. Khashayar P, Heshmat R, Qorbani M, Motlagh ME, Aminaee T, Ardalan G, et al. Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: The CASPIAN III Study. Int J Endocrinol. 2013; 2013: 702095[DOI][PubMed]
  • 12. Atlas of selected results of the 2011 national population and housing census Statistical center of Iran 2014;
  • 13. Abdolvahab M, Behnaz K, Sima B, M T. Hepatitis a in young adults in the golestan province, northeast of iran. J Glob Infect Dis. 2010; 2(2): 198-9[DOI][PubMed]
  • 14. Sofian M, Aghakhani A, Farazi AA, Banifazl M, Etemadi G, Azad-Armaki S, et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010; 8(3): 176-9[DOI][PubMed]
  • 15. Miri R, Ghezeldasht SA, Hedayati-Moghadam MR, Fathimoghadam F, Bidkhori H, Shamsian SA, et al. Seropositivity of antibodies against hepatitis a virus in mashhad, northeast of iran, 2009: A cross-sectional community-based study. Razavi Int J Med. 2015; 3(2)
  • 16. Ghasemian R, Alian S. Age-specific seroprevalence of hepatitis A in SARI (northern part of IRAN). Int J Infect Dis. 2010; 14: 223[DOI]
  • 17. Ataei B, Nokhodian Z, Javadi AA, Kasaeyan N, Farajzadegan Z, Shoaei P, et al. Seroepidemiology of hepatitis a virus infections in over 6-years population in isfahan, iran: A community-based study. Journal of Isfahan Medical School. 2008; 25(86): 46-53
  • 18. Taghavi Ardakani A, Soltani B, Sehat M, Namjoo S, Haji Rezaei M. Seroprevalence of anti-hepatitis a antibody among 1 - 15 year old children in kashan-iran. Hepat Mon. 2013; 13(5): 10553[DOI][PubMed]
  • 19. Noroozi M, Moradi F, Hasanzadeh A, Banazadegan R, Basiri MR, Ramezani A, et al. Seroprevalence of hepatitis a and hepatitis e in qom province, 2011. Iran J Infect Dis Trop Med. 2012; 17(58): 19-23
  • 20. Saffar MJ, Abedian O, Ajami A, Abedian F, Mirabi AM, Khalilian AR, et al. Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review. Hepat Mon. 2012; 12(5): 326-32[DOI][PubMed]
  • 21. Hosseini Shokouh SJ, Dadashi A, Abiri M, Zohrevand I, Eshraghian A, Khoshdel A, et al. HAV Immunity in Iranian Medical Students. Hepat Mon. 2015; 15(3): 26219[DOI][PubMed]
  • 22. Ceran N, Yuksel Kocdogan F, Mert D, Erdem I, Dede B, Adaleti R, et al. Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. J Viral Hepat. 2012; 19(1): 72-6[DOI][PubMed]
  • 23. Erdogan MS, Otkun M, Tatman-Otkun M, Akata F, Ture M. The epidemiology of hepatitis a virus infection in children, in Edirne, Turkey. Eur J Epidemiol. 2004; 19(3): 267-73[PubMed]
  • 24. Halicioglu O, Akman SA, Tatar B, Atesli R, Kose S. Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey. Travel Med Infect Dis. 2012; 10(1): 43-7[DOI][PubMed]
  • 25. Kaya D, Guler E, Ekerbicer HC, Dilber C, Karabiber H, Guler S, et al. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey. J Viral Hepat. 2007; 14(12): 830-4[DOI][PubMed]
  • 26. Alkhalidi J, Alenezi B, Al-Mufti S, Hussain E, Askar H, Kemmer N, et al. Seroepidemiology of hepatitis A virus in Kuwait. World J Gastroenterol. 2009; 15(1): 102-5[PubMed]
  • 27. Salama I, Samy SM, Shaaban FA, Hassanin AI, Abou Ismail LA. Seroprevalence of hepatitis A among children of different socioeconomic status in Cairo. East Mediterr Health J. 2007; 13(6): 1256-64[PubMed]
  • 28. Hayajneh WA, Balbeesi A, Faouri S. Hepatitis A virus age-specific sero-prevalence and risk factors among Jordanian children. J Med Virol. 2015; 87(4): 569-74[DOI][PubMed]
  • 29. Kotwal A, Singh H, Verma AK, Gupta RM, Jain S, Sinha S, et al. A study of Hepatitis A and E virus seropositivity profile amongst young healthy adults in India. Med J Armed Forces India. 2014; 70(3): 225-9[DOI][PubMed]
  • 30. Pinheiro RS, Araujo LA, Caetano KA, Matos MA, Carneiro MA, Teles SA. Intermediate Endemicity of Hepatitis a Virus Infection in Rural Settlement Projects of Southwest Goias, Brazil. Arq Gastroenterol. 2015; 52(3): 200-3[DOI][PubMed]
  • 31. Duval B, De Serres G, Ochnio J, Scheifele D, Gilca V. Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old. Pediatr Infect Dis J. 2005; 24(6): 514-9[PubMed]
  • 32. Melhem NM, Talhouk R, Rachidi H, Ramia S. Hepatitis A virus in the Middle East and North Africa region: a new challenge. J Viral Hepat. 2014; 21(9): 605-15[DOI][PubMed]
  • 33. Inter-agency regional response for Syrian refugees health and nutrition bulletin: Iraq, Jordan and Lebanon, January-March 2014 2014;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments